arrow
M

Massimiliano Fabbiani

University of Siena
H指数:35
被引数:6,190

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cumulative exposure to integrase inhibitors and metabolic factors as independent predictors of severe hepatic steatosis in people with HIV

整合酶抑制剂和代谢因素的累积暴露作为HIV感染者严重肝脂肪变性的独立预测因子

2026-10-210
OAAI
Memory B cell response to SARS-CoV-2 vaccination in people with heart and lung transplantation: Identification of associated clinical factors

心肺移植受者对SARS-CoV-2疫苗接种的记忆B细胞反应:相关临床因素的鉴定

2026-09-070
OAAI
Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature

使用头孢地尔治疗肺移植术后肺炎:一个病例系列及文献见解

2025-12-190
PRE
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153

抗原非依赖性鉴定靶向OPG153的痘病毒广谱中和抗体

2025-12-100
PRE
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: Epidemiology, clinical features and outcomes in the era of antimicrobial resistance

革兰阴性菌引起的老年住院患者尿路感染:在抗菌药物耐药时代的流行病学、临床特征及预后

2025-06-110
OAAI
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study)
2025-04-010
PRE
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses
2024-09-011
OAAI
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study

美罗培南vabobactam治疗kpc-kp感染患者的预后和死亡率预测因素: 一项观察性多中心研究

2024-05-087
OAAI
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant

mRNA或腺病毒载体疫苗的同源或异源给药对SARS-CoV-2 Omicron变体显示出相当的免疫原性和有效性

2024-04-024
OA
Sexually transmitted infections in people with multidrug-resistant HIV

耐多药HIV感染者的性传播感染

AIDS
IF3.1
2023-11-161
PRE
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
2023-01-0415
OAAI